T. Rowe Price Associates’s Zepp Health ZEPP Stock Holding History

T. Rowe Price Associates’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.73M	Buy	311,913 +15,946	+5%	+$326K	﹤0.01%	1548
2025 Q4	$7.97M	Buy	295,967 +44,619	+18%	+$1.59M	﹤0.01%	1276
2025 Q3	$11.5M	Buy	+251,348	New	+$7.61M	﹤0.01%	1192
2019 Q4	–	Sell	-23,417	Closed	-$937K	–	2555
2019 Q3	$937K	Sell	23,417 -5,534	-19%	-$232K	﹤0.01%	1850
2019 Q2	$1.16M	Sell	28,951 -14,092	-33%	-$588K	﹤0.01%	1788
2019 Q1	$2.25M	Buy	+43,043	New	+$2.32M	﹤0.01%	1557

Other funds holding ZEPP

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Monolith Management Hong Kong $332M AUM 119.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

T. Rowe Price Associates's ZEPP Position: Q1 2026 in Review

T. Rowe Price Associates increased its Zepp Health (ZEPP) stake by 5.4% in Q1 2026, buying an estimated $326K and bringing the position to 311,913 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

T. Rowe Price Associates first reported a position in ZEPP in Q1 2019 and has held it in 6 quarters since. The position peaked at $11.5M in Q3 2025. 32 funds tracked by Wall St. Rank hold ZEPP as of Q1 2026.

T. Rowe Price Associates held 311,913 shares of Zepp Health worth $3.73M as of Q1 2026.
T. Rowe Price Associates bought 15,946 Zepp Health shares in Q1 2026, an estimated $326K.
Zepp Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1548 holding.
T. Rowe Price Associates first reported a position in Zepp Health in Q1 2019 and has held it in 6 quarters since.
T. Rowe Price Associates's Zepp Health position peaked at $11.5M in Q3 2025.
32 funds tracked by Wall St. Rank held Zepp Health as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.